Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines

References

• Iwamoto T. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull 2013;36:715–18.
   PubMed Web of Science ®Google Scholar
• Barar J, Omidi Y. Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals. BioImpacts 2013;3:105–9.
   PubMedGoogle Scholar
• Omidi Y, Barar J, Heidari HR, et al. Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells. Toxicol Mech Meth 2008;18:369–78.
   PubMed Web of Science ®Google Scholar
• Hollins AJ, Omidi Y, Benter IF, Akhtar S. Toxicogenomics of drug delivery systems: exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J Drug Target 2007;15:83–8.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Hollins AJ, Drayton RM, Akhtar S. Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. J Drug Target 2005;13:431–43.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Barar J, Akhtar S. Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. Curr Drug Deliv 2005;2:429–41.
   PubMedGoogle Scholar
• Omidi Y, Hollins AJ, Benboubetra M, et al. Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J Drug Target 2003;11:311–23.
   PubMed Web of Science ®Google Scholar
• Barar J, Kafil V, Majd MH, et al. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. J Nanobiotechnol 2015;13:26.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Asgari D, Barar J, et al. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target 2013;21:328–40.
   PubMed Web of Science ®Google Scholar
• Omidi Y. Smart multifunctional theranostics: simultaneous diagnosis and therapy of cancer. BioImpacts 2011;1:145–7.
   PubMedGoogle Scholar
• Johari-Ahar M, Barar J, Alizadeh AM, et al. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells. J Drug Target 2016;24:120–33.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Asgari D, Barar J, et al. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Colloids Surf B Biointerfaces 2013;106:117–25.
   PubMed Web of Science ®Google Scholar
• Barar J, Omidi Y. Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. BioImpacts 2014;4:3–14.
   PubMedGoogle Scholar
• Omidi Y, Barar J. Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines. BioImpacts 2014;4:55–67.
   PubMedGoogle Scholar
• Barar J, Omidi Y. Dysregulated pH in tumor microenvironment checkmates cancer therapy. BioImpacts 2013;3:149–62.
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.
   PubMed Web of Science ®Google Scholar
• Cornelissen B, Able S, Kersemans V, et al. Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials 2013;34:1146–54.
   PubMed Web of Science ®Google Scholar
• Hong H, Yang K, Zhang Y, et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 2012;6:2361–70.
   PubMed Web of Science ®Google Scholar
• Shi S, Yang K, Hong H, et al. VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. Biomaterials 2015;39:39–46.
   PubMed Web of Science ®Google Scholar
• Eskandani M, Barar J, Dolatabadi JE, et al. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles. Pharm Biol 2015;53:1525–38.
   PubMed Web of Science ®Google Scholar
• Lin TY, Zhang H, Luo J, et al. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine 2012;7:2793–804.
   PubMed Web of Science ®Google Scholar
• Lee JL, Ahn JH, Park SH, et al. Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Invest New Drugs 2012;30:1984–90.
   PubMed Web of Science ®Google Scholar
• Sharma V, Anandhakumar S, Sasidharan M. Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug delivery. Mater Sci Eng C 2015;56:393–400.
   PubMed Web of Science ®Google Scholar
• Fathi M, Barar J, Aghanejad A, Omidi Y. Hydrogels for ocular drug delivery and tissue engineering. BioImpacts 2015;5:159–64.
   PubMed Web of Science ®Google Scholar
• Matthaiou EI, Barar J, Sandaltzopoulos R, et al. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. Int J Nanomedicine 2014;9:1855–70.
   PubMed Web of Science ®Google Scholar
• Ali-Boucetta H, Bitounis D, Raveendran-Nair R, et al. Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity. Adv Healthcare Mater 2013;2:433–41.
   Web of Science ®Google Scholar
• Fiorillo M, Verre AF, Iliut M, et al. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for nontoxic cancer treatment, via “differentiation-based nano-therapy”. Oncotarget 2015;6:3553–62.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhu S, Wang M, et al. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. ACS Appl Mater Interfaces 2015;7:1355–63.
   PubMed Web of Science ®Google Scholar
• Viraka Nellore BP, Pramanik A, Chavva SR, et al. Aptamer-conjugated theranostic hybrid graphene oxide with highly selective biosensing and combined therapy capability. Faraday Discuss 2014;175:257–71.
   PubMed Web of Science ®Google Scholar
• Yang L, Tseng YT, Suo G, et al. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination. ACS Appl Mater Interfaces 2015;7:5097–106.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC. Capture of stealth nanoparticles by the body’s defences. Crit Rev Therap Drug Carr Syst 2001;18:527–50.
   PubMed Web of Science ®Google Scholar
• Almeida JP, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 2011;6:815–35.
   PubMed Web of Science ®Google Scholar
• Ernsting MJ, Murakami M, Roy A, Li SD. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release 2013;172:782–94.
   PubMed Web of Science ®Google Scholar
• Liu X, Tao H, Yang K, et al. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011;32:144–51.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003;42:463–78.
   PubMed Web of Science ®Google Scholar
• Owens DE, 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Del Rev 2012;64:206–12.
   Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283–318.
   PubMed Web of Science ®Google Scholar
• Gbadamosi JK, Hunter AC, Moghimi SM. PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Lett 2002;532:338–44.
   PubMed Web of Science ®Google Scholar
• Brambilla D, Verpillot R, Le Droumaguet B, et al. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease. ACS Nano 2012;6:5897–908.
   PubMed Web of Science ®Google Scholar
• Moghimi SM. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumor growth. J Control Release 2014;190:556–62.
   PubMed Web of Science ®Google Scholar
• Robinson JT, Tabakman SM, Liang Y, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 2011;133:6825–31.
   PubMed Web of Science ®Google Scholar
• Li C, Sasaroli D, Chen X, et al. Tumor vascular biomarkers: new opportunities for cancer diagnostics. Cancer Biomark 2010;8:253–71.
   PubMed Web of Science ®Google Scholar
• Baselga J. eacute Herceptin® alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Oncology 2001;61:14–21.
   PubMed Web of Science ®Google Scholar
• Vose J, Link B, Grossbard M, et al. Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin’s lymphoma. J Clin Oncol 2001;19:389–97.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Vehmeijer LJ, Kok RJ, et al. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Del Rev 2013;65:1284–98.
   PubMed Web of Science ®Google Scholar
• Howard CB, Fletcher N, Houston ZH, et al. Overcoming instability of antibody-nanomaterial conjugates: next generation targeted nanomedicines using bispecific antibodies. Adv Healthc Mater 2016;5:2055–68.
   PubMed Web of Science ®Google Scholar
• Mi C, Zhang J, Gao H, et al. Multifunctional nanocomposites of superparamagnetic (Fe3O4) and NIR-responsive rare earth-doped up-conversion fluorescent (NaYF4: Yb,Er) nanoparticles and their applications in biolabeling and fluorescent imaging of cancer cells. Nanoscale 2010;2:1141–8.
   PubMed Web of Science ®Google Scholar
• Motz GT, Santoro SP, Wang LP, et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med 2014;20:607–15.
   PubMed Web of Science ®Google Scholar
• Lanitis E, Irving M, Coukos G. Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol 2015;33:55–63.
   PubMed Web of Science ®Google Scholar
• Hong H, Zhang Y, Engle JW, et al. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials 2012;33:4147–56.
   PubMed Web of Science ®Google Scholar
• Mauro N, Scialabba C, Cavallaro G, et al. Biotin-containing reduced graphene oxide-based nanosystem as a multieffect anticancer agent: combining hyperthermia with targeted chemotherapy. Biomacromolecules 2015;16:2766–75.
   PubMed Web of Science ®Google Scholar
• Ding H, Lv Y, Ni D, et al. Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programed delivery for photodynamic therapy of cancer. Nanoscale 2015;7:9806–15.
   PubMed Web of Science ®Google Scholar
• Maawy AA, Hiroshima Y, Zhang Y, et al. Polyethylene glycol (PEG) linked to near infrared (NIR) dyes conjugated to chimeric anti-carcinoembryonic antigen (CEA) antibody enhances imaging of liver metastases in a nude-mouse model of human colon cancer. PLoS One 2014;9:e97965.
   Google Scholar
• MacNeill CM, Coffin RC, Carroll DL, Levi-Polyachenko NH. Low band gap donor-acceptor conjugated polymer nanoparticles and their NIR-mediated thermal ablation of cancer cells. Macromol Biosci 2013;13:28–34.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Liu D, et al. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Biomaterials 2013;34:7715–24.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Min Y, Hu Q, et al. NIR photoregulated chemo- and photodynamic cancer therapy based on conjugated polyelectrolyte-drug conjugate encapsulated upconversion nanoparticles. Nanoscale 2014;6:11259–72.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Jiang X, Li B, et al. Hydrous RuO2 nanoparticles as an efficient NIR-light induced photothermal agent for ablation of cancer cells in vitro and in vivo. Nanoscale 2015;7:11962–70.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang H, Chen Y, et al. pH- and NIR light-responsive polymeric prodrug micelles for hyperthermia-assisted site-specific chemotherapy to reverse drug resistance in cancer treatment. Small 2016;12:2731–40.
   PubMed Web of Science ®Google Scholar
• Mikhaylov G, Mikac U, Magaeva AA, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol 2011;6:594–602.
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, et al. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 2011;32:6291–301.
   PubMed Web of Science ®Google Scholar
• Vlaskou D, Mykhaylyk O, Krötz F, et al. Magnetic and acoustically active lipospheres for magnetically targeted nucleic acid delivery. Adv Funct Mater 2010;20:3881–94.
   Web of Science ®Google Scholar
• Barar J. Bioimpacts of nanoparticle size: why it matters? BioImpacts 2015;5:1135.
   Web of Science ®Google Scholar
• Robinson JT, Welsher K, Tabakman SM, et al. High performance in vivo near-IR (>1 µm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res 2010;3:779–93.
   PubMed Web of Science ®Google Scholar
• Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008;269:57–66.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang L, Wang J, et al. Mesoporous silica‐coated gold nanorods as a light‐mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012;24:1418–23.
   PubMed Web of Science ®Google Scholar
• Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 2011;32:1121–9.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dutta S, Gomes E, et al. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009;3:2667–73.
   PubMed Web of Science ®Google Scholar
• Li C, Wang X, Chen F, et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials 2013;34:3882–90.
   PubMed Web of Science ®Google Scholar
• Sanchez VC, Jachak A, Hurt RH, Kane AB. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2011;25:15–34.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu H, Zhao C, et al. One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. Biomaterials 2014;35:4986–95.
   PubMed Web of Science ®Google Scholar
• Offeman R, Hummers W. Preparation of graphitic oxide. J Am Chem Soc 1958;80:1339.
   Web of Science ®Google Scholar
• Khan M, Khan M, Al-Marri AH, et al. Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer. Int J Nanomedicine 2016;11:873–83.
   PubMed Web of Science ®Google Scholar
• Ma X, Tao H, Yang K, et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 2012;5:199–212.
   Web of Science ®Google Scholar
• Shen J, Hu Y, Shi M, et al. Fast and facile preparation of graphene oxide and reduced graphene oxide nanoplatelets. Chem Mater 2009;21:3514–20.
   Web of Science ®Google Scholar
• Zhu Y, Stoller MD, Cai W, et al. Exfoliation of graphite oxide in propylene carbonate and thermal reduction of the resulting graphene oxide platelets. ACS Nano 2010;4:1227–33.
   PubMed Web of Science ®Google Scholar
• Niyogi S, Bekyarova E, Itkis ME, et al. Solution properties of graphite and graphene. J Am Chem Soc 2006;128:7720–1.
   PubMed Web of Science ®Google Scholar
• Stankovich S, Piner RD, Nguyen ST, Ruoff RS. Synthesis and exfoliation of isocyanate-treated graphene oxide nanoplatelets. Carbon 2006;44:3342–7.
   Web of Science ®Google Scholar
• Xu C, Wu X, Zhu J, Wang X. Synthesis of amphiphilic graphite oxide. Carbon 2008;46:386–9.
   Web of Science ®Google Scholar
• Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008;1:203–12.
   PubMed Web of Science ®Google Scholar
• You P, Yang Y, Wang M, et al. Graphene oxide-based nanocarriers for cancer imaging and drug delivery. Curr Pharm Design 2015;21:3215–22.
   PubMed Web of Science ®Google Scholar
• Bao H, Pan Y, Ping Y, et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 2011;7:1569–78.
   PubMed Web of Science ®Google Scholar
• Liao KH, Lin YS, Macosko CW, Haynes CL. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 2011;3:2607–15.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhao Y, Fang J, Wang D. Immune response is required for the control of in vivo translocation and chronic toxicity of graphene oxide. Nanoscale 2014;6:5894–906.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhao Y, Li Y, Wang D. Molecular signals regulating translocation and toxicity of graphene oxide in the nematode Caenorhabditis elegans. Nanoscale 2014;6:11204–12.
   PubMed Web of Science ®Google Scholar
• Pieper H, Chercheja S, Eigler S, et al. Endoperoxides revealed as origin of the toxicity of graphene oxide. Angew Chem Int Ed Engl 2016;55:405–7.
   PubMed Web of Science ®Google Scholar
• Wu W, Yan L, Wu Q, et al. Evaluation of the toxicity of graphene oxide exposure to the eye. Nanotoxicology 2016;10:1329–40.
   PubMed Web of Science ®Google Scholar
• Wen KP, Chen YC, Chuang CH, et al. Accumulation and toxicity of intravenously-injected functionalized graphene oxide in mice. J Appl Toxicol 2015;35:1211–18.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Youn YS, Jeong JH, et al. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells. Colloids Surf B Biointerfaces 2016;143:271–7.
   PubMed Web of Science ®Google Scholar
• Hu Y, He L, Ding J, et al. One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy. Carbohydr Polym 2016;144:223–9.
   PubMed Web of Science ®Google Scholar
• Tian J, Luo Y, Huang L, et al. PEGylated folate and peptide-decorated graphene oxide nanovehicle for in vivo targeted delivery of anticancer drugs and therapeutic self-monitoring. Biosen Bioelectron 2016;80:519–24.
   PubMed Web of Science ®Google Scholar
• Zheng XT, Ma XQ, Li CM. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide. J Colloid Interface Sci 2016;467:35–42.
   PubMed Web of Science ®Google Scholar
• Lv Y, Tao L, Annie Bligh SW, et al. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Mater Sci Eng C Mater Biol Appl 2016;59:652–60.
   PubMed Web of Science ®Google Scholar
• Yang H, Bremner DH, Tao L, et al. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Carbohydr Polym 2016;135:72–8.
   PubMed Web of Science ®Google Scholar
• Tran TH, Nguyen HT, Pham TT, et al. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer. ACS Appl Mater Interfaces 2015;7:28647–55.
   PubMed Web of Science ®Google Scholar
• Hou L, Feng Q, Wang Y, et al. Multifunctional hyaluronic acid modified graphene oxide loaded with mitoxantrone for overcoming drug resistance in cancer. Nanotechnology 2016;27:015701.
   Google Scholar
• Yang K, Zhang S, Zhang G, et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010;10:3318–23.
   PubMed Web of Science ®Google Scholar
• Wang H, Gu W, Xiao N, et al. Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug. Int J Nanomedicine 2014;9:1433–42.
   PubMed Web of Science ®Google Scholar
• Qu F, Li T, Yang M. Colorimetric platform for visual detection of cancer biomarker based on intrinsic peroxidase activity of graphene oxide. Biosens Bioelectron 2011;26:3927–31.
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhou X, Xing D. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials 2014;35:4185–94.
   PubMed Web of Science ®Google Scholar
• Qin X, Guo Z, Liu Z, et al. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B Biol 2013;120:156–62.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010;6:537–44.
   PubMed Web of Science ®Google Scholar
• Sahu A, Choi WI, Lee JH, Tae G. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 2013;34:6239–48.
   PubMed Web of Science ®Google Scholar
• Shi X, Gong H, Li Y, et al. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials 2013;34:4786–93.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang K, Zhao J, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc 2013;135:4799–804.
   PubMed Web of Science ®Google Scholar
• Akhavan O, Ghaderi E, Emamy H. Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy. J Mater Chem 2012;22:20626–33.
   Web of Science ®Google Scholar
• Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 2008;130:10876–7.
   PubMed Web of Science ®Google Scholar
• Tian B, Wang C, Zhang S, et al. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011;5:7000–9.
   PubMed Web of Science ®Google Scholar
• Feng L, Yang X, Shi X, et al. Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small 2013;9:1989–97.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Song L, Zheng J, et al. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials 2013;34:5236–43.
   PubMed Web of Science ®Google Scholar
• Miao W, Shim G, Lee S, et al. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials 2013;34:3402–10.
   PubMed Web of Science ®Google Scholar
• Zhang W, Guo Z, Huang D, et al. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 2011;32:8555–61.
   PubMed Web of Science ®Google Scholar
• Akhavan O, Ghaderi E, Aghayee S, et al. The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy. J Mater Chem 2012;22:13773–81.
   Web of Science ®Google Scholar
• Shi S, Yang K, Hong H, et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials 2013;34:3002–9.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Barar J. Impacts of blood-brain barrier in drug delivery and targeting of brain tumors. BioImpacts 2012;2:5–22.
   PubMedGoogle Scholar
• Dong H, Jin M, Liu Z, et al. In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for Gliomas. Lasers Med Sci 2016;31:1123–31.
   PubMed Web of Science ®Google Scholar
• Rosen LS, Hurwitz HI, Wong MK, et al. A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin Cancer Res 2012;18:4820–9.
   PubMed Web of Science ®Google Scholar
• Leamon CP. Folate-targeted drug strategies for the treatment of cancer. Curr Opin Investig Drugs 2008;9:1277–86.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Barar J, Asgari D, et al. Targeted fluoromagnetic nanoparticles for imaging of breast cancer MCF-7 cells. Adv Pharm Bull 2013;3:189–95.
   PubMedGoogle Scholar
• Martinez AW, Phillips ST, Whitesides GM, Carrilho E. Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem 2009;82:3–10.
   Web of Science ®Google Scholar
• Zhao W, Ali MM, Aguirre SD, et al. Paper-based bioassays using gold nanoparticle colorimetric probes. Anal Chem 2008;80:8431–7.
   PubMed Web of Science ®Google Scholar
• Tang D, Ren J. In situ amplified electrochemical immunoassay for carcinoembryonic antigen using horseradish peroxidase-encapsulated nanogold hollow microspheres as labels. Anal Chem 2008;80:8064–70.
   PubMed Web of Science ®Google Scholar
• Papsidero LD, Wang MC, Valenzuela LA, et al. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980;40:2428–32.
   PubMed Web of Science ®Google Scholar
• LeBeau AM, Singh P, Isaacs JT, Denmeade SR. Prostate-specific antigen is a “chymotrypsin-like” serine protease with unique P1 substrate specificity. Biochemistry 2009;48:3490–6.
   PubMed Web of Science ®Google Scholar
• Li JL, Tang B, Yuan B, et al. A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials 2013;34:9519–34.
   PubMed Web of Science ®Google Scholar
• Hu D, Zhang J, Gao G, et al. Indocyanine green-loaded polydopamine-reduced graphene oxide nanocomposites with amplifying photoacoustic and photothermal effects for cancer theranostics. Theranostics 2016;6:1043–52.
   PubMed Web of Science ®Google Scholar
• Li Q, Hong L, Li H, Liu C. Graphene oxide-fullerene C60 (GO-C60) hybrid for photodynamic and photothermal therapy triggered by near-infrared light. Biosens Bioelectron 2016. [Epub ahead of print]. doi: 10.1016/j.bios.2016.03.072.
   Web of Science ®Google Scholar
• Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128:2115–20.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang D, Xi J, et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 2007;7:1318–22.
   PubMed Web of Science ®Google Scholar
• Yavuz MS, Cheng Y, Chen J, et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009;8:935–9.
   PubMed Web of Science ®Google Scholar
• Wu X, Ming T, Wang X, et al. High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. ACS Nano 2009;4:113–20.
   Web of Science ®Google Scholar
• Dong W, Li Y, Niu D, et al. Theranostic nanoshells: facile synthesis of monodisperse superparamagnetic Fe3O4 Core@ hybrid@ Au shell nanocomposite for bimodal imaging and photothermal therapy (Adv. Mater. 45/2011). Adv Mater 2011;23:5332.
   Web of Science ®Google Scholar
• Cheng L, Yang K, Li Y, et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual‐targeted photothermal therapy. Angew Chem 2011;123:7523–8.
   Google Scholar
• Zedan AF, Moussa S, Terner J, et al. Ultrasmall gold nanoparticles anchored to graphene and enhanced photothermal effects by laser irradiation of gold nanostructures in graphene oxide solutions. ACS Nano 2012;7:627–36.
   PubMed Web of Science ®Google Scholar
• Huang X, Li S, Huang Y, et al. Synthesis of hexagonal close-packed gold nanostructures. Nat Commun 2011;2:292.
   PubMed Web of Science ®Google Scholar
• Mashinchian O, Johari-Ahar M, Ghaemi B, et al. Impacts of quantum dots in molecular detection and bioimaging of cancer. BioImpacts 2014;4:149–66.
   PubMedGoogle Scholar
• Hu D-H, Sheng Z-H, Zhang P-F, et al. Hybrid gold-gadolinium nanoclusters for tumor-targeted NIRF/CT/MRI triple-modal imaging in vivo. Nanoscale 2013;5:1624–8.
   PubMed Web of Science ®Google Scholar
• Song L, Kim C, Maslov K, et al. High-speed dynamic 3D photoacoustic imaging of sentinel lymph node in a murine model using an ultrasound array. Med Phys 2009;36:3724–9.
   PubMed Web of Science ®Google Scholar
• Song L, Maslov K, Wang LV. Section-illumination photoacoustic microscopy for dynamic 3D imaging of microcirculation in vivo. Optics Lett 2010;35:1482–4.
   PubMed Web of Science ®Google Scholar
• Meng J, Wang LV, Liang D, Song L. In vivo optical-resolution photoacoustic computed tomography with compressed sensing. Optics Lett 2012;37:4573-5.
   PubMed Web of Science ®Google Scholar
• Elsadek B, Kratz F. Impact of albumin on drug delivery-new applications on the horizon. J Control Release 2012;157:4–28.
   PubMed Web of Science ®Google Scholar
• Cao J, An H, Huang X, et al. Monitoring of the tumor response to nano-graphene oxide-mediated photothermal/photodynamic therapy by diffusion-weighted and BOLD MRI. Nanoscale 2016;8:10152–9.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhong X, Yi X, et al. Radionuclide (131)I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer. Biomaterials 2015;66:21–8.
   PubMed Web of Science ®Google Scholar
• Yang K, Wan J, Zhang S, et al. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012;33:2206–14.
   PubMed Web of Science ®Google Scholar
• Xu L, Xiang J, Liu Y, et al. Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity. Nanoscale 2016;8:3785–95.
   PubMed Web of Science ®Google Scholar
• Kalluru P, Vankayala R, Chiang CS, Hwang KC. Nano-graphene oxide-mediated in vivo fluorescence imaging and bimodal photodynamic and photothermal destruction of tumors. Biomaterials 2016;95:1–10.
   PubMed Web of Science ®Google Scholar
• Kafil V, Omidi Y. Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells. BioImpacts 2011;1:23–30.
   PubMedGoogle Scholar
• Ahmadian S, Barar J, Saei AA, Fakhree MA, Omidi Y. Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay. JoVE 2009;26:1–2.
   PubMedGoogle Scholar
• Chen H, Liu Z, Li S, et al. Fabrication of graphene and AuNP core polyaniline shell nanocomposites as multifunctional theranostic platforms for SERS real-time monitoring and chemo-photothermal therapy. Theranostics 2016;6:1096–104.
   PubMed Web of Science ®Google Scholar
• Huang P, Wang S, Wang X, et al. Surface functionalization of chemically reduced graphene oxide for targeted photodynamic therapy. J Biomed Nanotechnol 2015;11:117–25.
   PubMed Web of Science ®Google Scholar